BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
Interest Expense
BioPlus Co Ltd
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Interest Expense
₩263.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SD Biosensor Inc
KRX:137310
|
Interest Expense
₩68.6B
|
CAGR 3-Years
420%
|
CAGR 5-Years
207%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Interest Expense
₩12.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
16%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Interest Expense
₩19.6m
|
CAGR 3-Years
71%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Interest Expense
₩1.9B
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
21%
|
|
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.
See Also
What is BioPlus Co Ltd's Interest Expense?
Interest Expense
263.4m
KRW
Based on the financial report for Dec 31, 2024, BioPlus Co Ltd's Interest Expense amounts to 263.4m KRW.
What is BioPlus Co Ltd's Interest Expense growth rate?
Interest Expense CAGR 5Y
25%
Over the last year, the Interest Expense growth was 337%. The average annual Interest Expense growth rates for BioPlus Co Ltd have been -20% over the past three years , 25% over the past five years .
